TrialLancet (London, England)2016

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.

Russell E Ware et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.